Bluebird bio, Inc. (BLUE):企業の財務及び戦略的SWOT分析

GlobalDataが発行した調査報告書(GDPH137067FSA)
◆英語タイトル:Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH137067FSA
◆発行会社(リサーチ会社):GlobalData
◆発行日:2016年1月9日
◆ページ数:25
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥32,100見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥64,200見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥96,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary

bluebird bio, Inc. (bluebird bio) is a biotechnology company that research and develops new gene therapies for the treatment of severe genetic and orphan diseases. The company offers products which include LentiGlobin, used for beta thalassemia and sickle cell anemia; Lenti D; and CAR T cells, used to treat cancer. Its gene therapy process includes inserting genetic material into the patient’s own cells ex vivo, then re-introducing the cells to the patient. The company has collaborations with Celgene Corporation to discover, develop and commercialize disease-altering gene therapy products in oncology. It was formerly known as Genetix Pharmaceuticals. GENETIX is headquartered in Cambridge, Massachusetts, the US.

Bluebird bio, Inc. Key Recent Developments

Dec 06, 2015: bluebird bio Presents Pre-Clinical and Manufacturing Data from CAR T Oncology Programs at ASH Annual Meeting
Nov 04, 2015: bluebird bio Reports Third Quarter 2015 Financial Results and Recent Operational Progress
Sep 29, 2015: Alexandria Real Estate Equities Announces 10-Year 253,000 RSF Full-Building Build-to-Suit Lease at 60 Binney Street for bluebird bio for Its New Office/Laboratory Headquarters in the Heart of Kendall Square in Cambridge
Aug 06, 2015: bluebird bio Reports Second Quarter 2015 Financial Results and Recent Operational Progress
Jun 15, 2015: Philip Gregory, D. Phil., Joins bluebird bio as Chief Scientific Officer

This comprehensive SWOT profile of Bluebird bio, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Bluebird bio, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Bluebird bio, Inc. – Key Information
Bluebird bio, Inc. – Overview
Bluebird bio, Inc. – Key Employees
Bluebird bio, Inc. – Key Employee Biographies
Bluebird bio, Inc. – Key Operational Heads
Bluebird bio, Inc. – Major Products and Services
Bluebird bio, Inc. – History
Bluebird bio, Inc. – Company Statement
Bluebird bio, Inc. – Locations And Subsidiaries
Bluebird bio, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Bluebird bio, Inc. – Business Description
Bluebird bio, Inc. – Corporate Strategy
Bluebird bio, Inc. – SWOT Analysis
SWOT Analysis – Overview
Bluebird bio, Inc. – Strengths
Bluebird bio, Inc. – Weaknesses
Bluebird bio, Inc. – Opportunities
Bluebird bio, Inc. – Threats
Bluebird bio, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Bluebird bio, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Bluebird bio, Inc., Key Information
Bluebird bio, Inc., Key Ratios
Bluebird bio, Inc., Share Data
Bluebird bio, Inc., Major Products and Services
Bluebird bio, Inc., History
Bluebird bio, Inc., Key Employees
Bluebird bio, Inc., Key Employee Biographies
Bluebird bio, Inc., Key Operational Heads
Bluebird bio, Inc., Other Locations
Bluebird bio, Inc., Subsidiaries
Bluebird bio, Inc., Key Manufacturing facilities
Bluebird bio, Inc., Key Competitors
Bluebird bio, Inc., SWOT Analysis
Bluebird bio, Inc., Ratios based on current share price
Bluebird bio, Inc., Annual Ratios
Bluebird bio, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Bluebird bio, Inc., Performance Chart
Bluebird bio, Inc., Ratio Charts

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Bluebird bio, Inc. (BLUE):企業の財務及び戦略的SWOT分析(Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆